Japanese patent for HIV immuno-monitoring:
This article was originally published in Clinica
Cel-Sci has received a Japanese patent for an immunodiagnostic technique that monitors HIV progression. The assay, which is under development at the University of Maryland, measures the levels of antibodies that bind to HIV-1 p17 peptides in serum. Cel-Sci plans to develop a test that is cheaper than genetic amplification tests.
You may also be interested in...
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.
Alvotech has struck a major deal with Yangtze River Pharmaceutical that will allow eight of the biosimilars developer’s products to be commercialized in China.